Logo image of REBN

REBORN COFFEE INC (REBN) Stock Fundamental Analysis

NASDAQ:REBN - Nasdaq - US75618M3051 - Common Stock - Currency: USD

2.71  -0.06 (-2.17%)

Fundamental Rating

2

Taking everything into account, REBN scores 2 out of 10 in our fundamental rating. REBN was compared to 41 industry peers in the Consumer Staples Distribution & Retail industry. REBN may be in some trouble as it scores bad on both profitability and health. While showing a medium growth rate, REBN is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year REBN has reported negative net income.
REBN had a negative operating cash flow in the past year.
REBN had negative earnings in each of the past 5 years.
REBN had a negative operating cash flow in each of the past 5 years.
REBN Yearly Net Income VS EBIT VS OCF VS FCFREBN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 -1M -2M -3M -4M

1.2 Ratios

The Return On Assets of REBN (-61.70%) is worse than 97.56% of its industry peers.
REBN's Return On Equity of -184.65% is on the low side compared to the rest of the industry. REBN is outperformed by 92.68% of its industry peers.
Industry RankSector Rank
ROA -61.7%
ROE -184.65%
ROIC N/A
ROA(3y)-49.38%
ROA(5y)-56.98%
ROE(3y)-173.87%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
REBN Yearly ROA, ROE, ROICREBN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 0 100 -100 -200

1.3 Margins

REBN's Gross Margin of 62.82% is amongst the best of the industry. REBN outperforms 97.56% of its industry peers.
In the last couple of years the Gross Margin of REBN has remained more or less at the same level.
The Profit Margin and Operating Margin are not available for REBN so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 62.82%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.17%
GM growth 5YN/A
REBN Yearly Profit, Operating, Gross MarginsREBN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 0 50 -50 -100 -150

More info and screens

1

2. Health

2.1 Basic Checks

REBN does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, REBN has more shares outstanding
The debt/assets ratio for REBN has been reduced compared to a year ago.
REBN Yearly Shares OutstandingREBN Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 1M 2M 3M 4M
REBN Yearly Total Debt VS Total AssetsREBN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 2M 4M 6M 8M

2.2 Solvency

REBN has an Altman-Z score of -3.93. This is a bad value and indicates that REBN is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of -3.93, REBN is not doing good in the industry: 97.56% of the companies in the same industry are doing better.
REBN has a Debt/Equity ratio of 0.35. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.35, REBN is in line with its industry, outperforming 56.10% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.35
Debt/FCF N/A
Altman-Z -3.93
ROIC/WACCN/A
WACC15.5%
REBN Yearly LT Debt VS Equity VS FCFREBN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 0 2M -2M 4M -4M

2.3 Liquidity

A Current Ratio of 0.31 indicates that REBN may have some problems paying its short term obligations.
With a Current ratio value of 0.31, REBN is not doing good in the industry: 95.12% of the companies in the same industry are doing better.
A Quick Ratio of 0.25 indicates that REBN may have some problems paying its short term obligations.
REBN has a Quick ratio of 0.25. This is in the lower half of the industry: REBN underperforms 78.05% of its industry peers.
Industry RankSector Rank
Current Ratio 0.31
Quick Ratio 0.25
REBN Yearly Current Assets VS Current LiabilitesREBN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 1M 2M 3M

More info and screens

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 29.87% over the past year.
Looking at the last year, REBN shows a decrease in Revenue. The Revenue has decreased by -0.43% in the last year.
REBN shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 37.51% yearly.
EPS 1Y (TTM)29.87%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%41.75%
Revenue 1Y (TTM)-0.43%
Revenue growth 3Y37.51%
Revenue growth 5YN/A
Sales Q2Q%-1.11%

3.2 Future

The Earnings Per Share is expected to grow by 126.37% on average over the next years. This is a very strong growth
Based on estimates for the next years, REBN will show a very strong growth in Revenue. The Revenue will grow by 52.11% on average per year.
EPS Next Y260%
EPS Next 2Y164.58%
EPS Next 3Y126.37%
EPS Next 5YN/A
Revenue Next Year64.55%
Revenue Next 2Y57.31%
Revenue Next 3Y52.11%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
REBN Yearly Revenue VS EstimatesREBN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 10M 20M 30M 40M 50M
REBN Yearly EPS VS EstimatesREBN Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 0 -0.5 -1

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

REBN reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
A Price/Forward Earnings ratio of 33.21 indicates a quite expensive valuation of REBN.
REBN's Price/Forward Earnings is on the same level as the industry average.
When comparing the Price/Forward Earnings ratio of REBN to the average of the S&P500 Index (21.94), we can say REBN is valued expensively.
Industry RankSector Rank
PE N/A
Fwd PE 33.21
REBN Price Earnings VS Forward Price EarningsREBN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
REBN Per share dataREBN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
REBN's earnings are expected to grow with 126.37% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y164.58%
EPS Next 3Y126.37%

More info and screens

0

5. Dividend

5.1 Amount

REBN does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

REBORN COFFEE INC

NASDAQ:REBN (5/21/2025, 8:00:01 PM)

2.71

-0.06 (-2.17%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupConsumer Staples Distribution & Retail
GICS IndustryConsumer Staples Distribution & Retail
Earnings (Last)11-14 2022-11-14/amc
Earnings (Next)N/A N/A
Inst Owners2.67%
Inst Owner Change0.85%
Ins Owners48.02%
Ins Owner Change-0.73%
Market Cap12.38M
Analysts82.86
Price TargetN/A
Short Float %2.36%
Short Ratio0.59
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 33.21
P/S 2.09
P/FCF N/A
P/OCF N/A
P/B 4.76
P/tB 4.76
EV/EBITDA N/A
EPS(TTM)-1.73
EYN/A
EPS(NY)0.08
Fwd EY3.01%
FCF(TTM)-1
FCFYN/A
OCF(TTM)-0.76
OCFYN/A
SpS1.3
BVpS0.57
TBVpS0.57
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -61.7%
ROE -184.65%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 62.82%
FCFM N/A
ROA(3y)-49.38%
ROA(5y)-56.98%
ROE(3y)-173.87%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.17%
GM growth 5YN/A
F-Score3
Asset Turnover0.76
Health
Industry RankSector Rank
Debt/Equity 0.35
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 283.52%
Cap/Sales 18.71%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.31
Quick Ratio 0.25
Altman-Z -3.93
F-Score3
WACC15.5%
ROIC/WACCN/A
Cap/Depr(3y)332.07%
Cap/Depr(5y)258.1%
Cap/Sales(3y)18.95%
Cap/Sales(5y)17.35%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)29.87%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%41.75%
EPS Next Y260%
EPS Next 2Y164.58%
EPS Next 3Y126.37%
EPS Next 5YN/A
Revenue 1Y (TTM)-0.43%
Revenue growth 3Y37.51%
Revenue growth 5YN/A
Sales Q2Q%-1.11%
Revenue Next Year64.55%
Revenue Next 2Y57.31%
Revenue Next 3Y52.11%
Revenue Next 5YN/A
EBIT growth 1Y-19.12%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year684.52%
EBIT Next 3Y187.41%
EBIT Next 5YN/A
FCF growth 1Y-19.71%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-23.69%
OCF growth 3YN/A
OCF growth 5YN/A